Overview
Resolve Biosciences offers Molecular Cartography™, a platform providing high-resolution spatial transcriptomics at subcellular resolution to map molecular interactions while preserving tissue samples. The technology supports applications in oncology, neuroscience, and infectious disease by enabling analysis of tumor heterogeneity, immune interactions, and biomarker development. Customers in North America and Europe can access commercial services for sample submission and data analysis.
Frequently asked questions
- What is Molecular Cartography™?
- Molecular Cartography™ is a proprietary, highly multiplexed, single-molecule detection platform that delivers the highest-resolution view of subcellular gene expression and spatial biology, preserving sample tissue for future analysis.
- What are the key applications for pharma and life sciences?
- Applications include investigating tumor heterogeneity, immune cell states, ligand-receptor interactions, biomarker identification, and mapping complex tissue architectures in oncology, neuroscience, and infectious disease.
- What regions do they serve and how to access services?
- Resolve Biosciences provides commercial Molecular Cartography services to customers in North America and Europe through sample submission to their labs in Monheim am Rhein, Germany, and San Jose, California.